TOTAL VOLUME:

$154.3b

24H VOL:

$228,458,490

24H TRANSACTIONS:

2,984,028,936

OPEN INTEREST:

$1,879,276,037

410,833

Markets across

40,345

events

MATCHED EVENTS:

4,363

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
BC Komarno vs Kosice Wolves
kalshi

BC Komarno vs Kosice Wolves

Volume:
$1,483

Kosice Wolves

 - Kalshi

Kosice Wolves - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 24, 2026

Closed: Oct 24, 2:51 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Kosice Wolves

View
100%
Yes 100¢No 0¢
—
N/A
$1,149
N/A
N/A
$1,122
Settled
Yes
kalshi

BC Komarno

View
0%
Yes 0¢No 100¢
—
N/A
$335
N/A
N/A
$330
Settled
No
Total markets: 2

Description

This market centers on the outcome of a professional basketball game between BC Komarno and Kosice Wolves, reflecting the competitive performance of both teams in their scheduled match. The result depends solely on which team secures a victory in the contest. Any changes to the game's timing or cancellation will impact how the market ultimately settles.

Kalshi

The event determines the winner of the men's professional Slovakia SBL basketball game between BC Komarno and Kosice Wolves, scheduled for October 24, 2026, at 1:00 PM EDT. If Kosice Wolves win, their corresponding market resolves to Yes, and BC Komarno's market resolves to No. Conversely, if BC Komarno wins, their market resolves to Yes, and Kosice Wolves' market resolves to No. Should the game be postponed but commence within 48 hours of the original start time, both markets remain open and resolve based on the final official result. If the game is cancelled or fails to start within this 48-hour window, all markets resolve to a fair price, ensuring equitable treatment for all participants.